Eris Lifesciences reported a significant 200% year-on-year increase in net profit to ₹281.6 crore for Q4 FY26. Following this robust financial performance, the company announced an interim dividend of 721% (₹7.21 per share). This news propelled the stock price to an all-time high of ₹1,495, marking a 12% jump during intraday trading. The company's revenue also grew by 7% to ₹757 crore, driven by strong demand for its pharmaceutical products in the domestic market. https://kannada.asianetnews.com/business/eris-lifesciences-q4-results-profit-rises-281-crore-721-percent-dividend-san/articleshow-mg52t4n #creator program